OWENS & MINOR INC (OMI) Stock Fundamental Analysis
USA - NYSE:OMI - US6907321029 - Common Stock
5.2 USD
-0.14 (-2.62%)
5.3 USD
+0.1 (+1.92%)
We assign a fundamental rating of 3 out of 10 to OMI. OMI was compared to 101 industry peers in the Health Care Providers & Services industry. While OMI is still in line with the averages on profitability rating, there are concerns on its financial health. OMI has a valuation in line with the averages, but it does not seem to be growing.
1. Profitability
1.1 Basic Checks
In the past year OMI was profitable.
OMI had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: OMI reported negative net income in multiple years.
Each year in the past 5 years OMI had a positive operating cash flow.
1.2 Ratios
OMI has a worse Return On Assets (-28.95%) than 84.16% of its industry peers.
Looking at the Return On Invested Capital, with a value of 13.26%, OMI belongs to the top of the industry, outperforming 90.10% of the companies in the same industry.
OMI had an Average Return On Invested Capital over the past 3 years of 6.37%. This is below the industry average of 9.19%.
The last Return On Invested Capital (13.26%) for OMI is above the 3 year average (6.37%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -28.95% | ||
| ROE | N/A | ||
| ROIC | 13.26% |
ROA(3y)-2.73%
ROA(5y)-0.2%
ROE(3y)-22.09%
ROE(5y)-7.69%
ROIC(3y)6.37%
ROIC(5y)8.64%
1.3 Margins
OMI has a Operating Margin (2.85%) which is comparable to the rest of the industry.
OMI's Operating Margin has improved in the last couple of years.
OMI's Gross Margin of 22.79% is in line compared to the rest of the industry. OMI outperforms 48.51% of its industry peers.
In the last couple of years the Gross Margin of OMI has grown nicely.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 2.85% | ||
| PM (TTM) | N/A | ||
| GM | 22.79% |
OM growth 3Y-17.34%
OM growth 5Y15.68%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y10.28%
GM growth 5Y11.1%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so OMI is creating value.
The number of shares outstanding for OMI has been increased compared to 1 year ago.
OMI has more shares outstanding than it did 5 years ago.
The debt/assets ratio for OMI has been reduced compared to a year ago.
2.2 Solvency
OMI has an Altman-Z score of 1.95. This is not the best score and indicates that OMI is in the grey zone with still only limited risk for bankruptcy at the moment.
The Altman-Z score of OMI (1.95) is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | N/A | ||
| Altman-Z | 1.95 |
ROIC/WACC1.81
WACC7.34%
2.3 Liquidity
OMI has a Current Ratio of 0.86. This is a bad value and indicates that OMI is not financially healthy enough and could expect problems in meeting its short term obligations.
The Current ratio of OMI (0.86) is worse than 81.19% of its industry peers.
OMI has a Quick Ratio of 0.86. This is a bad value and indicates that OMI is not financially healthy enough and could expect problems in meeting its short term obligations.
OMI has a worse Quick ratio (0.83) than 76.24% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.86 | ||
| Quick Ratio | 0.83 |
3. Growth
3.1 Past
The earnings per share for OMI have decreased strongly by -13.10% in the last year.
The Earnings Per Share has been growing by 22.10% on average over the past years. This is a very strong growth
The Revenue for OMI has decreased by -17.10% in the past year. This is quite bad
The Revenue has been growing slightly by 3.04% on average over the past years.
EPS 1Y (TTM)-13.1%
EPS 3Y-28.62%
EPS 5Y22.1%
EPS Q2Q%-27.78%
Revenue 1Y (TTM)-17.1%
Revenue growth 3Y3.03%
Revenue growth 5Y3.04%
Sales Q2Q%-74.47%
3.2 Future
OMI is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 2.95% yearly.
Based on estimates for the next years, OMI will show a very negative growth in Revenue. The Revenue will decrease by -26.35% on average per year.
EPS Next Y-32.85%
EPS Next 2Y-18.88%
EPS Next 3Y-8.32%
EPS Next 5Y2.95%
Revenue Next Year-74.03%
Revenue Next 2Y-49.09%
Revenue Next 3Y-35.45%
Revenue Next 5Y-26.35%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 3.56, the valuation of OMI can be described as very cheap.
Based on the Price/Earnings ratio, OMI is valued cheaper than 100.00% of the companies in the same industry.
When comparing the Price/Earnings ratio of OMI to the average of the S&P500 Index (27.27), we can say OMI is valued rather cheaply.
Based on the Price/Forward Earnings ratio of 5.20, the valuation of OMI can be described as very cheap.
Based on the Price/Forward Earnings ratio, OMI is valued cheaper than 99.01% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 22.77. OMI is valued rather cheaply when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 3.56 | ||
| Fwd PE | 5.2 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of OMI indicates a rather cheap valuation: OMI is cheaper than 94.06% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 4.72 |
4.3 Compensation for Growth
A cheap valuation may be justified as OMI's earnings are expected to decrease with -8.32% in the coming years.
PEG (NY)N/A
PEG (5Y)0.16
EPS Next 2Y-18.88%
EPS Next 3Y-8.32%
5. Dividend
5.1 Amount
OMI does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
5.2
-0.14 (-2.62%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners103.24%
Inst Owner Change-0.36%
Ins Owners3.64%
Ins Owner Change1.46%
Market Cap401.65M
Analysts51.67
Price Target6.26 (20.38%)
Short Float %9.94%
Short Ratio4.79
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)5.19%
Min EPS beat(2)-6.28%
Max EPS beat(2)16.66%
EPS beat(4)3
Avg EPS beat(4)3.96%
Min EPS beat(4)-6.28%
Max EPS beat(4)16.66%
EPS beat(8)7
Avg EPS beat(8)6.12%
EPS beat(12)10
Avg EPS beat(12)14.68%
EPS beat(16)13
Avg EPS beat(16)14.84%
Revenue beat(2)0
Avg Revenue beat(2)-38.63%
Min Revenue beat(2)-75.28%
Max Revenue beat(2)-1.97%
Revenue beat(4)1
Avg Revenue beat(4)-19.33%
Min Revenue beat(4)-75.28%
Max Revenue beat(4)0.52%
Revenue beat(8)1
Avg Revenue beat(8)-10.02%
Revenue beat(12)5
Avg Revenue beat(12)-5.72%
Revenue beat(16)8
Avg Revenue beat(16)-4.2%
PT rev (1m)-38.6%
PT rev (3m)-38.6%
EPS NQ rev (1m)-44.57%
EPS NQ rev (3m)-46.01%
EPS NY rev (1m)-39.04%
EPS NY rev (3m)-40.07%
Revenue NQ rev (1m)-62.15%
Revenue NQ rev (3m)-62.13%
Revenue NY rev (1m)-74.73%
Revenue NY rev (3m)-74.92%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 3.56 | ||
| Fwd PE | 5.2 | ||
| P/S | 0.05 | ||
| P/FCF | N/A | ||
| P/OCF | 3.98 | ||
| P/B | N/A | ||
| P/tB | N/A | ||
| EV/EBITDA | 4.72 |
EPS(TTM)1.46
EY28.08%
EPS(NY)1
Fwd EY19.24%
FCF(TTM)-2.15
FCFYN/A
OCF(TTM)1.31
OCFY25.11%
SpS113.04
BVpS-3.64
TBVpS-22.06
PEG (NY)N/A
PEG (5Y)0.16
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -28.95% | ||
| ROE | N/A | ||
| ROCE | 16.79% | ||
| ROIC | 13.26% | ||
| ROICexc | 13.61% | ||
| ROICexgc | 1049.61% | ||
| OM | 2.85% | ||
| PM (TTM) | N/A | ||
| GM | 22.79% | ||
| FCFM | N/A |
ROA(3y)-2.73%
ROA(5y)-0.2%
ROE(3y)-22.09%
ROE(5y)-7.69%
ROIC(3y)6.37%
ROIC(5y)8.64%
ROICexc(3y)6.65%
ROICexc(5y)8.97%
ROICexgc(3y)17.92%
ROICexgc(5y)17.9%
ROCE(3y)8.06%
ROCE(5y)10.94%
ROICexcg growth 3Y-4.88%
ROICexcg growth 5Y26.45%
ROICexc growth 3Y-21.55%
ROICexc growth 5Y13.72%
OM growth 3Y-17.34%
OM growth 5Y15.68%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y10.28%
GM growth 5Y11.1%
F-Score4
Asset Turnover2.1
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 3.22 | ||
| Cap/Depr | 108.01% | ||
| Cap/Sales | 3.06% | ||
| Interest Coverage | 1.82 | ||
| Cash Conversion | 20.34% | ||
| Profit Quality | N/A | ||
| Current Ratio | 0.86 | ||
| Quick Ratio | 0.83 | ||
| Altman-Z | 1.95 |
F-Score4
WACC7.34%
ROIC/WACC1.81
Cap/Depr(3y)77.12%
Cap/Depr(5y)69.93%
Cap/Sales(3y)1.94%
Cap/Sales(5y)1.4%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-13.1%
EPS 3Y-28.62%
EPS 5Y22.1%
EPS Q2Q%-27.78%
EPS Next Y-32.85%
EPS Next 2Y-18.88%
EPS Next 3Y-8.32%
EPS Next 5Y2.95%
Revenue 1Y (TTM)-17.1%
Revenue growth 3Y3.03%
Revenue growth 5Y3.04%
Sales Q2Q%-74.47%
Revenue Next Year-74.03%
Revenue Next 2Y-49.09%
Revenue Next 3Y-35.45%
Revenue Next 5Y-26.35%
EBIT growth 1Y-19.73%
EBIT growth 3Y-14.84%
EBIT growth 5Y19.2%
EBIT Next Year85.47%
EBIT Next 3Y28.56%
EBIT Next 5YN/A
FCF growth 1Y-139.12%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-83.91%
OCF growth 3Y9.15%
OCF growth 5Y-0.56%